Nancy Lurker, President & CEO at EyePoint Pharmaceuticals, Inc. (EYPT), bought 28,500 shares at $1.76 ($50K) on 2019-03-29, disclosed to the SEC on 2019-04-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| EYPT | SELL | 2025-12-01 | $10K | — | Filing → |
| EYPT | BUY | 2024-08-20 | $25K | — | Filing → |
| EYPT | SELL | 2024-01-25 | $1.7M | — | Filing → |